Conavi Medical Corp.
CNVI.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 58.17% | 72.97% | 34.17% | 31.90% | -124.18% |
| Total Depreciation and Amortization | 24.21% | -17.57% | -33.08% | -30.74% | -27.16% |
| Total Amortization of Deferred Charges | -82.15% | -- | -- | -- | -20.99% |
| Total Other Non-Cash Items | -77.23% | -120.09% | -175.84% | -178.47% | 4,681.82% |
| Change in Net Operating Assets | -141.07% | -212.17% | 487.69% | 500.86% | -6.99% |
| Cash from Operations | -10.45% | -40.23% | -13.73% | -17.67% | 17.36% |
| Capital Expenditure | 93.14% | 94.55% | 82.98% | 82.39% | -1.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -87.25% | 100.00% | 1,926.12% | 1,988.10% | -10.22% |
| Cash from Investing | 51.92% | 95.86% | 789.29% | 813.20% | -3.35% |
| Total Debt Issued | -- | -- | -- | -- | 767.32% |
| Total Debt Repaid | -77.06% | -91.93% | -47.61% | -47.61% | 50.87% |
| Issuance of Common Stock | -- | -- | 168,100.00% | 168,100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -110.70% | 301.06% | 1,722.16% | 1,778.25% | -80.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -311.36% | 965.41% | 105.01% | 105.18% | -111.63% |